Home
News
Events
12th HTAsiaLink Conference 2025

Events

12th HTAsiaLink Conference 2025

19 August 2025

12th HTAsiaLink Conference 2025

Event date: 19 Aug 2025 - 22 Aug 2025

Location: Singapore EXPO, 1 Expo Drive, Singapore 486150

Call for Abstracts

We are now accepting abstracts for the 2025 Conference! The Conference offers an exceptional platform to showcase your research and engage with peers.

Submission Timeline

Please take note of the following key deadlines below:

Abstract submissions open: 06 January 2025

Abstract submissions close: 14 March 2025, 6:00PM SGT (Extended)

Announcement of results to shortlisted abstract authors: By April 2025

Tracks

3 tracks available for abstract submission

Track 1: Economic Evaluation	Track 2: Health Services Research	Track 3: Others
Economic evaluation topic areas include: Cost studies (including cost of illness and resource use) Cost comparison Budget impact analysis Thresholds and opportunity cost Trial-based economic evaluation Indirect health costs Value of information Novel and social elements of value.¹	Health services research is the multidisciplinary field of scientific investigation that studies how Social factors Financing systems Organizational structures and processes Health technologies Personal behaviours affect access to health care, the quality and cost of health care, and ultimately our health and well-being.² Topic areas include policy analysis, qualitative studies or mixed methods.	This track encompasses all research areas not specifically covered in Track 1 or 2. It can include diverse health-related studies, including but not limited to: Evidence synthesis: systematic reviews, meta-analysis, network meta-analysis, scoping reviews Data science: observational studies, real-world evidence
¹ISPOR. About Economic Evaluation. ISPOR. Accessed November 7, 2024. https://www.ispor.org/heor-resources/heor-by-topic-new/economic-evaluation. ²Lohr KN, Steinwachs DM. Health services research: an evolving definition of the field. Health Serv Res. 2002;37(1):7-9.

Track 1: Economic Evaluation

Track 2: Health Services Research

Track 3: Others

Economic evaluation topic areas include:

Cost studies (including cost of illness and resource use)
Cost comparison
Budget impact analysis
Thresholds and opportunity cost
Trial-based economic evaluation
Indirect health costs
Value of information
Novel and social elements of value.¹

Health services research is the multidisciplinary field of scientific investigation that studies how

Social factors
Financing systems
Organizational structures and processes
Health technologies
Personal behaviours
affect access to health care, the quality and cost of health care, and ultimately our health and well-being.²

Topic areas include policy analysis, qualitative studies or mixed methods.

This track encompasses all research areas not specifically covered in Track 1 or 2. It can include diverse health-related studies, including but not limited to:

Evidence synthesis: systematic reviews, meta-analysis, network meta-analysis, scoping reviews
Data science: observational studies, real-world evidence

¹ISPOR. About Economic Evaluation. ISPOR. Accessed November 7, 2024. https://www.ispor.org/heor-resources/heor-by-topic-new/economic-evaluation.

²Lohr KN, Steinwachs DM. Health services research: an evolving definition of the field. Health Serv Res. 2002;37(1):7-9.

Resources

Refer to the abstract submission guideline document [PDF, 511 KB] on how to submit an abstract.
Use the abstract template form [PDF, 86.8 KB] to submit your abstract.
All abstracts must be submitted electronically via this link.

For enquires on the abstract submissions, please contact the HTAsiaLink Conference 2025 Committee at htasialink_2025_secretariat@moh.gov.sg.

Conference Theme

Unlocking Value through Health Technology Assessment (HTA) in Asia: Forging Ahead Together

Join us in Singapore for the 12th HTAsiaLink Conference in 2025, where experts and leaders from the Asia Pacific region will converge to explore and advance the role of Health Technology Assessment (HTA) in unlocking value within our healthcare systems. The 2025 conference theme emphasises the power of collaboration as we forge ahead together, addressing shared challenges and opportunities in the region.

Who Should Attend:

Members and associate members of HTAsiaLink

There are no fees for participating in the conference and all members are responsible for their own costs.

Stay tuned for detailed conference information, including the conference programme and keynote speakers. Registration will open soon!

Schedule-at-a-Glance

Schedule of the 12th HTAsiaLink Conference 2025

Plenary 1 - Exploring the Multiverse of Healthcare through HTA: Diverse perspectives, unified outcomes

This plenary focuses on the diversity of HTA in terms of methodologies, types of health technologies or programs, and initiatives shaping the dynamic landscape. The diverse ways HTA is used across countries and settings, HTA harmonisation efforts, methods for equitable evaluation in HTA, and the importance of the patient perspective in HTA are the main themes that will be discussed.

List of Moderators and Panelists

Moderator	Panelists
A/Prof Wanrudee Isaranuwatchai Health Intervention and Technology Assessment Program (HITAP) Thailand	Dr Eri Hoshino Center for Outcomes Research and Economic Evaluation for Health (C2H), Japan. As a member of INAHTA Topic: Diversity of HTA approaches across countries/settings & associated challenges; insights beyond Asia Pacific Ms Anne Julienne Marfori Department of Science and Technology (DOST) Philippines Topic: ASEAN HTA Harmonization Project: Common assessment methods, reporting formats & joint assessments in HTAs in the region Prof Sitanshu Sekhar Kar Equity in Asia-Pacific Health Systems (EquitAP-HTA) Topic: Addressing equity in HTA: Insights and Applications of Distributional Cost-Effectiveness Analysis (DCEA) in policy making Dr Simon Fifer Community and Patient Preference Research (CaPPRe) Topic: Importance of incorporating patient preference data into HTA as real-world evidence

Moderator

Panelists

A/Prof Wanrudee Isaranuwatchai
Health Intervention and Technology Assessment Program (HITAP)
Thailand

Dr Eri Hoshino
Center for Outcomes Research and Economic Evaluation for Health (C2H), Japan. As a member of INAHTA
Topic: Diversity of HTA approaches across countries/settings & associated challenges; insights beyond Asia Pacific

Ms Anne Julienne Marfori
Department of Science and Technology (DOST) Philippines
Topic: ASEAN HTA Harmonization Project: Common assessment methods, reporting formats & joint assessments in HTAs in the region

Prof Sitanshu Sekhar Kar
Equity in Asia-Pacific Health Systems (EquitAP-HTA)
Topic: Addressing equity in HTA: Insights and Applications of Distributional Cost-Effectiveness Analysis (DCEA) in policy making

Dr Simon Fifer
Community and Patient Preference Research (CaPPRe)
Topic: Importance of incorporating patient preference data into HTA as real-world evidence

Plenary 2 - The Road Ahead: Navigating Possibilities with HTA

This plenary session, co-organised with Saw Swee Hock School of Public Health, will explore the critical role of HTA in shaping the future of data-driven, artificial intelligence (AI)-empowered personalised medicine (PM). The advent of big health data analytics has enabled the synergies between AI and PM, which are mainly divided into four groups: digital diagnostics, therapy planning, risk prediction, disease self-management. As these innovative technologies rapidly and simultaneously evolve, HTA serves as a key framework to assess their clinical effectiveness, economic value, equity and ethical implications, ensuring they deliver meaningful benefits to patients and healthcare systems.

List of Moderators and Panelists

Moderator	Panelists
A/Prof Wee Hwee Lin Saw Swee Hock School of Public Health Singapore	Kelly Lenahan The professional society for health economics and outcomes research ISPOR Topic: Updates from ISPOR Global HTA Roundtable with focus on successes & opportunities; Results from use of AI in HEOR ISPOR workgroup A/Prof Chen Wenjia Saw Swee Hock School of Public Health Singapore Topic: Overview of the current landscape of HTA and reimbursement of AI-PM Dr Mark Sculpher University of York United Kingdom Topic: Methodologies of evaluation of AI-PM in HTA Dr Xiao Yue National Center for Medicine and Health Technology Assessment of China Topic: Real-world practice and challenges in evaluating AI-PM with HTA; the China experience

Moderator

Panelists

A/Prof Wee Hwee Lin
Saw Swee Hock School of Public Health
Singapore

Kelly Lenahan
The professional society for health economics and outcomes research ISPOR
Topic: Updates from ISPOR Global HTA Roundtable with focus on successes & opportunities; Results from use of AI in HEOR ISPOR workgroup

A/Prof Chen Wenjia
Saw Swee Hock School of Public Health Singapore
Topic: Overview of the current landscape of HTA and reimbursement of AI-PM

Dr Mark Sculpher
University of York United Kingdom
Topic: Methodologies of evaluation of AI-PM in HTA

Dr Xiao Yue
National Center for Medicine and Health Technology Assessment of China
Topic: Real-world practice and challenges in evaluating AI-PM with HTA; the China experience

Plenary 3 - Translating HTA into Impactful Results: Value-based Healthcare

The session discusses how HTA helps to achieve value-based healthcare (VBHC), showcasing the importance of implementation strategies to drive adoption of cost-effective health technologies, and measurement systems to understand the impact of HTA on health outcomes and healthcare systems. International health economics outcomes research, translation of evidence to policy guidelines at a national level, the role of price volume agreements and risk sharing agreements in VBHC, and perspectives on the practical application of VBHC towards tangible measurable outcomes will be discussed.

List of Moderators and Panelists

Moderator	Panelists
Dr Huang Li-Ying (Grace) Center for Drug Evaluation Taiwan	Dr Joanne Yoong The professional society for health economics and outcomes research ISPOR VBHC taskforce Topic: Findings & recommendations on role of HEOR and HTA in VBHC implementation from ISPOR VBHC Task Force Dr Kavitha Rajsekar Ministry of Health and Family Welfare India Topic: Translation of HTA evidence into policy guidelines for cost saving at a national level in India Ms Lin Liang Agency for Care Effectiveness Singapore Topic: Role and use of HTA in implementing VBHC in Singapore Dr Yot Teerawattananon Health Intervention and Technology Assessment Program (HITAP) Thailand Topic: Translation of HTA into meaningful preventive services & public health programmes Dr Wija Oortwijn Radboud University Medical Center, the Netherlands

Moderator

Panelists

Dr Huang Li-Ying (Grace)
Center for Drug Evaluation Taiwan

Dr Joanne Yoong
The professional society for health economics and outcomes research
ISPOR VBHC taskforce
Topic: Findings & recommendations on role of HEOR and HTA in VBHC implementation from ISPOR VBHC Task Force
Dr Kavitha Rajsekar
Ministry of Health and Family Welfare India
Topic: Translation of HTA evidence into policy guidelines for cost saving at a national level in India
Ms Lin Liang
Agency for Care Effectiveness Singapore
Topic: Role and use of HTA in implementing VBHC in Singapore
Dr Yot Teerawattananon
Health Intervention and Technology Assessment Program (HITAP) Thailand
Topic: Translation of HTA into meaningful preventive services & public health programmes

Dr Wija Oortwijn
Radboud University Medical Center, the Netherlands

Sharing Session by Prof Mark Jit and Prof Alex Cook

Prof Mark Jit and Prof Alex Cook will present the draft recommendations of the Lancet Commission on epidemiological modelling, and the evidence that informed them. They will then discuss how the recommendations can be used to support health technology assessment of infectious disease interventions.

List of Speakers

Speakers
Prof Mark Jit London School of Hygiene & Tropical Medicine United Kingdom
Prof Alex Cook Saw Swee Hock School of Public Health Singapore

Pre-conference workshop schedule

Legend

Blue: Exploring the Multiverse of Healthcare through HTA

Purple: The Road Ahead: Navigating AI-empowered Precision Medicine Possibilities with HTA

Orange: Translating HTA into Impactful Results: Value-Based Healthcare